Cynosure Group LLC Sells 316 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Cynosure Group LLC cut its holdings in Addus HomeCare Co. (NASDAQ:ADUS) by 11.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,438 shares of the company’s stock after selling 316 shares during the quarter. Cynosure Group LLC’s holdings in Addus HomeCare were worth $306,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of ADUS. Quarry LP bought a new position in Addus HomeCare during the third quarter worth $28,000. Smartleaf Asset Management LLC raised its holdings in shares of Addus HomeCare by 324.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock valued at $35,000 after purchasing an additional 214 shares during the period. Parkside Financial Bank & Trust boosted its position in shares of Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock worth $67,000 after purchasing an additional 148 shares in the last quarter. Meeder Asset Management Inc. acquired a new stake in shares of Addus HomeCare in the 4th quarter valued at about $77,000. Finally, Harvest Fund Management Co. Ltd bought a new stake in Addus HomeCare in the 4th quarter valued at about $86,000. 95.35% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

ADUS has been the topic of several recent research reports. Oppenheimer increased their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Macquarie reissued an “outperform” rating and issued a $129.00 price target on shares of Addus HomeCare in a research report on Thursday, February 27th. StockNews.com downgraded shares of Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. Stephens reiterated an “overweight” rating and set a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. Finally, JMP Securities began coverage on shares of Addus HomeCare in a research report on Monday, December 16th. They set an “outperform” rating and a $150.00 target price for the company. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, Addus HomeCare has an average rating of “Moderate Buy” and an average target price of $132.78.

Addus HomeCare Stock Performance

Shares of ADUS stock opened at $99.88 on Thursday. The company has a market capitalization of $1.82 billion, a price-to-earnings ratio of 22.86, a PEG ratio of 1.41 and a beta of 0.93. Addus HomeCare Co. has a 52-week low of $87.88 and a 52-week high of $136.72. The company has a 50-day simple moving average of $106.22 and a two-hundred day simple moving average of $120.04.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The business had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. On average, sell-side analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.